23 results
Thumbnail

D1.76 - Contact dermatitis in diabetic patients with wearable devices: A single-centre study

Thumbnail

D1.87 - Kiwi allergy: A Comparative Analysis of Adult and Pediatric patients

Thumbnail

D1.77 - Hereditary Angioedema in Real Life: Unmet Needs from the Patient Perspective

Thumbnail

D1.78 - Non-Allergic Dermatologic Diagnoses Among Patients Presenting to an Allergy Immunology Outpatient Clinic: A Prospective Clinical Study

Thumbnail

D1.79 - Heterogeneity of Non-Allergic Non-Eosinophilic Asthma: Clinical Subphenotypes and Allergy Belief Patterns

Thumbnail

D1.82 - Pancake Syndrome: Molecular and Diagnostic Heterogeneity of Mite Sensitization

Thumbnail

D1.83 - Cannabis-related severe anaphylaxis without cutaneous manifestations: atypical sensitization profile and mast cell disorder differential diagnosis in a case report

Thumbnail

D1.84 - Invasion Meets Allergy: Cortaderia selloana as an Emerging Grass Aeroallergen

Thumbnail

D1.85 - Baseline lung function and clinical outcomes in Allergic Bronchopulmonary Mycosis: A real-world cohort from a Severe Asthma Multidisciplinary Unit

Thumbnail

D1.86 - Age-Related Features of Sensitization to Timothy Grass in Children According to Component-Resolved Diagnostics

Thumbnail

D1.88 - An unusual diagnostic aid for Hymenoptera venom genuine versus cross sensitization: the field sting

Thumbnail

D1.89 - Qualitative comparison between Euroline Respiratory Profile and Phadiatop for the screening of airborne allergies

Thumbnail

D1.189 - Does Allergen Immunotherapy Add Clinically Meaningful Benefit in Paediatric Asthma and Allergic Rhinitis? A 36-Month Real-World Comparison

Thumbnail

D1.192 - Combined Polymerized Pollen and Animal Dander Immunotherapy Improves Rhinoconjunctivitis and Asthma in Polysensitized Patients: Real-World Evidence

Thumbnail

D1.194 - Real-World Effectiveness of Polymerized Dog Allergen Immunotherapy in Allergic Rhinoconjunctivitis and Asthma

Thumbnail

D1.195 - Fc-Engagers as a targeted approach for antigen-specific immune inhibition in HDM allergy

Thumbnail

D1.197 - Safety and efficacy of a modified one-day ultra-rush protocol for the induction of Hymenoptera venom immunotherapy in patients with anaphylaxis in Switzerland

Thumbnail

D1.186 - Three years treatment with HDM injection allergen immunotherapy, omalizumab, or combination therapy in allergic asthma

Thumbnail

D1.187 - A Novel Volume-Reduced Desensitization Protocol for Pembrolizumab Hypersensitivity in Advanced Lung Cancer

Thumbnail

D1.188 - Adverse Reactions During Honey Bee Venom Immunotherapy as an Indicator of Underlying Clonal Mast Cell Disease Independent of Baseline Serum Tryptase: A Case Report